Melanoma News and Research

Latest Melanoma News and Research

Roche Signs Up To $422.5M Collaboration With Inovio

...

10 Sep 2013

Severity of sleep apnoea can independently predict aggressiveness of skin melanoma

The severity of sleep apnoea can independently predict the aggressiveness of malignant skin melanoma, according to a new study.

10 Sep 2013

Researchers investigate importance of STAT1 phosphorylation in NK cells

Since its discovery in the early 1990s, the protein STAT1 (Signal Transducer and Activator of Transcription 1) has been found to be central in passing signals across immune cells, ensuring that our bodies react quickly and appropriately to threats from viruses or other pathogens.

7 Sep 2013

Researchers start Phase I clinical trial of implantable vaccine for treatment of melanoma

A cross-disciplinary team of scientists, engineers, and clinicians announced today that they have begun a Phase I clinical trial of an implantable vaccine to treat melanoma, the most lethal form of skin cancer.

7 Sep 2013

New Sponge-Based Therapeutic Cancer Vaccine Begins Human Clinicals

...

6 Sep 2013

Viralytics releases financial results for 2013

Viralytics Limited (ASX:VLA, OTCQX:VRACY) has released its financial results for the year ended 30 June 2013.

3 Sep 2013

State highlights: Texas bans youth from tanning salons; Texas, Fla., have most uninsured; Medicare change threatens rural hospital funding in S.D.

Soon, Texas will join a number of states that bar minors from tanning indoors, which experts say greatly increases the risk of melanoma in those under 18. Senate Bill 329, written by State Senators Joan Huffman, Republican of Southside Place, and Sylvia R. Garcia, Democrat of Houston, automatically became law in June without the governor's signature and will take effect on Sunday (Serrano, 8/29).

31 Aug 2013

First Edition: August 30, 2013

Today's headlines include the latest news on congressional efforts to avert a financial crisis as well as coverage of the news from the Internal Revenue Service, Treasury Department and Department of Health and Human Services about how same-sex marriage will be recognized.

30 Aug 2013

Researchers raise awareness about ovarian cancers into synagogues across the country

This fall, the University of Pennsylvania's Basser Research Center for BRCA is taking its lifesaving efforts to raise awareness about hereditary breast and ovarian cancers on the road and into synagogues across the country.

30 Aug 2013

Scientists identify enzyme mutation that occurs in castration-resistant prostate cancer

The mutation occurs in the androgen-synthesizing enzyme 3βHSD1 in castration-resistant prostate cancer (CRPC), according to research published online today in Cell. This mutation enables the tumor to make its own supply of androgens, a hormone that fuels the growth of the prostate cancer.

30 Aug 2013

Researchers discover protein that may help predict breast cancer prognosis

Researchers have identified a protein that they believe may help predict breast cancer prognosis, potentially relieving thousands of women at low risk from having to undergo painful, oft-debilitating therapies, while insuring the most successful treatments for those at high risk. The research was published ahead of print in the journal Molecular and Cellular Biology.

30 Aug 2013

Experts share tips on preventing ovarian cancer

Ovarian cancer is the fourth leading cause of death in American women. Approximately 22,000 women are diagnosed annually and 14,000 die from the disease. September is Ovarian Cancer Awareness month and Mount Sinai experts are sharing tips on prevention.

29 Aug 2013

Oral sunscreens not as effective as traditional lotions and creams, warns Loyola dermatologist

While it might be nice to pop a pill to protect your skin from the sun, a Loyola University Health System dermatologist warns that oral sunscreens are not as effective as traditional lotions and creams.

29 Aug 2013

Researchers suggest new therapeutic target for brain tumor

Johns Hopkins researchers say they have found a specific protein in nearly 100 percent of high-grade meningiomas — the most common form of brain tumor — suggesting a new target for therapies for a cancer that does not respond to current chemotherapy.

28 Aug 2013

Researchers find specific protein in nearly all high-grade meningiomas

Johns Hopkins researchers say they have found a specific protein in nearly 100 percent of high-grade meningiomas -- the most common form of brain tumor -- suggesting a new target for therapies for a cancer that does not respond to current chemotherapy.

28 Aug 2013

Northwestern surgical oncologists use minimally invasive procedure to remove malignant melanoma

That's when she received the results from her dermatologist, who removed a part of the blister and had it tested. It turns out that little red bump was malignant melanoma, the leading cause of skin cancer death in the United States. It's a cancer that kills one person every hour, which translates to more than 8,700 Americans each year.

27 Aug 2013

FDA grants marketing approval for VALCHLOR gel for treatment of early stage CTCL

Ceptaris Therapeutics, Inc., a privately held, specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration has granted marketing approval for the orphan drug VALCHLOR (mechlorethamine) gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma in patients who have received prior skin-directed therapy.

26 Aug 2013

Moffitt Cancer Center study could offer hope to melanoma sufferers

A new study at Moffitt Cancer Center could offer hope to people with melanoma, the deadliest form of skin cancer. Researchers are investigating whether an injectable known as PV-10 can shrink tumors and reduce the spread of cancer.

23 Aug 2013

MC1R mutation responsible for red hair phenotype also promotes cancer-causing pathway

A person's skin pigment, which determines hair color and skin tone, is influenced by the melanocortin-1 (MC1R) gene receptor. For the population's one to two percent of redheads, a mutation in MC1R accounts for their red hair color and typical light skin.

23 Aug 2013

Advance team of molecules produced by primary tumor is responsible for lung cancer metastasis

Cancer metastasis requires tumor cells to acquire properties that allow them to escape from the primary tumor site, travel to a distant place in the body, and form secondary tumors. But first, an advance team of molecules produced by the primary tumor sets off a series of events that create a network of nurturing blood vessels for arriving primary tumor cells to set up shop.

20 Aug 2013

Melanoma News and Research

Latest Melanoma News and Research

Roche Signs Up To $422.5M Collaboration With Inovio

Severity of sleep apnoea can independently predict aggressiveness of skin melanoma

Researchers investigate importance of STAT1 phosphorylation in NK cells

Researchers start Phase I clinical trial of implantable vaccine for treatment of melanoma

New Sponge-Based Therapeutic Cancer Vaccine Begins Human Clinicals

Viralytics releases financial results for 2013

State highlights: Texas bans youth from tanning salons; Texas, Fla., have most uninsured; Medicare change threatens rural hospital funding in S.D.

First Edition: August 30, 2013

Researchers raise awareness about ovarian cancers into synagogues across the country

Scientists identify enzyme mutation that occurs in castration-resistant prostate cancer

Researchers discover protein that may help predict breast cancer prognosis

Experts share tips on preventing ovarian cancer

Oral sunscreens not as effective as traditional lotions and creams, warns Loyola dermatologist

Researchers suggest new therapeutic target for brain tumor

Researchers find specific protein in nearly all high-grade meningiomas

Northwestern surgical oncologists use minimally invasive procedure to remove malignant melanoma

FDA grants marketing approval for VALCHLOR gel for treatment of early stage CTCL

Moffitt Cancer Center study could offer hope to melanoma sufferers

MC1R mutation responsible for red hair phenotype also promotes cancer-causing pathway

Advance team of molecules produced by primary tumor is responsible for lung cancer metastasis

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Melanoma News and Research

Latest Melanoma News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in